These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2207291)

  • 1. Effects of cefotaxime on the serum protein binding of sulfisoxazole.
    du Souich P; Calvo R; Erill S
    Biopharm Drug Dispos; 1990 Jul; 11(5):371-9. PubMed ID: 2207291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between protein binding of bilirubin, salicylic acid, and sulfisoxazole in serum of unmedicated and phenobarbital-treated rats.
    Yacobi A; Oie S; Levy G
    J Pharm Sci; 1977 Jul; 66(7):1025-7. PubMed ID: 886438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of serum protein binding on sulfisoxazole distribution, metabolism, and excretion in rats.
    Yacobi A; Levy G
    J Pharm Sci; 1979 Jun; 68(6):742-6. PubMed ID: 458578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum protein binding of sulfisoxazole and diazepam in patients with chronic obstructive pulmonary disease.
    Guerrero J; García-Morillas M; Gil-Extremera B; Erill S
    Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):255-8. PubMed ID: 3596851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal serum protein binding of acidic drugs in diabetes mellitus.
    Ruiz-Cabello F; Erill S
    Clin Pharmacol Ther; 1984 Nov; 36(5):691-5. PubMed ID: 6488690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of hepatic cirrhosis on the plasma protein binding of drugs.
    García-Morillas M; Gil-Extremera B; Caracuel-Ruiz MD
    Int J Clin Pharmacol Res; 1984; 4(5):327-33. PubMed ID: 6519849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the disposition of total and unbound sulfisoxazole after single and multiple dosing.
    Oie S; Gambertoglio JG; Fleckenstein L
    J Pharmacokinet Biopharm; 1982 Apr; 10(2):157-72. PubMed ID: 7120046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum protein binding of model acidic drugs in smokers and non-smokers.
    Ruiz-Cabello F; Erill S
    Int J Clin Pharmacol Res; 1986; 6(3):177-9. PubMed ID: 3744622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilirubin-displacing effect of furosemide and sulfisoxazole. An in vitro and in vivo study in neonatal serum.
    Cashore WJ; Oh W; Brodersen R
    Dev Pharmacol Ther; 1983; 6(4):230-8. PubMed ID: 6617404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraindividual relationships between serum protein binding of drugs in normal human subjects, patients with impaired renal function, and rats.
    Yacobi A; Levy G
    J Pharm Sci; 1977 Sep; 66(9):1285-8. PubMed ID: 333094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding and disposition of sulfisoxazole in alcoholic cirrhosis.
    Cello JP; Oie S
    J Pharmacokinet Biopharm; 1985 Feb; 13(1):1-12. PubMed ID: 4020620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of carbamylation of plasma proteins and competitive displacers on drug binding in uremia.
    Calvo R; Carlos R; Erill S
    Pharmacology; 1982; 24(4):248-52. PubMed ID: 7089046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum protein binding and extravascular diffusion of methoxyimino cephalosporins. Time courses of free and total concentrations of cefotaxime and ceftriaxone in serum and pleural exudate.
    Scaglione F; Raichi M; Fraschini F
    J Antimicrob Chemother; 1990 Sep; 26 Suppl A():1-10. PubMed ID: 2228838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of cefotaxime and its metabolite, desacetylcefotaxime, in rat: application of a pharmacokinetic-protein binding model.
    Hakim L; Bourne DW; Triggs EJ
    Xenobiotica; 1989 Jul; 19(7):743-54. PubMed ID: 2773510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus].
    Vallée E; Joly-Guillou ML; Bergogne-Berezin E
    Presse Med; 1990 Apr; 19(13):588-91. PubMed ID: 2139937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing the protein binding of vancomycin.
    Shin WG; Lee MG; Lee MH; Kim ND
    Biopharm Drug Dispos; 1991 Dec; 12(9):637-46. PubMed ID: 1790309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of sulfisoxazole compared in humans and two monogastric animal species.
    Suber RL; Lee C; Torosian G; Edds GT
    J Pharm Sci; 1981 Sep; 70(9):981-4. PubMed ID: 6101167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential effect of sodium bicarbonate on disposition of sulfadimethoxine and sulfisoxazole in rabbits].
    Imamura Y; Murahashi N; Suenaga A; Otagiri M
    Yakugaku Zasshi; 1989 Jun; 109(6):432-6. PubMed ID: 2553915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma protein binding and half-life of sulphisoxazole (sulphafurazole).
    Shastri RA
    Br J Clin Pharmacol; 1982 Feb; 13(2):249-50. PubMed ID: 7059428
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vitro effect of cefixime against 200 strains of Branhamella catarrhalis. Comparison with cefotaxime].
    Chardon H; Bellon O; Lagier E; Giraud E
    Presse Med; 1989 Oct; 18(32):1556-9. PubMed ID: 2530531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.